Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors
Overview
Authors
Affiliations
Objective: The purpose of this study was to determine whether perfusion-weighted imaging (PWI) and proton MR spectroscopy (MRS) are useful in differentiating high- and low-grade oligodendroglial tumors.
Materials And Methods: PWI and MRS studies of 22 patients with histologically proven oligodendroglioma or oligoastrocytoma (13 low-grade and nine anaplastic tumors) were retrospectively reviewed. PWI of 14 subjects was performed with a dynamic contrast-enhanced susceptibility-weighted echo-planar technique. Intratumoral relative cerebral blood volume ratio was calculated and normalized to the same value in contralateral normal-appearing white matter. Multivoxel MRS was performed with a point-resolved spectroscopy sequence at a TE of 135 milliseconds in 20 patients and with the addition of a TE of 30 seconds in 17 patients. MRS data were expressed as intratumoral metabolite ratios (choline to creatine [Cho/Cr], choline to N-acetyl aspartate, N-acetyl aspartate to creatine, and myoinositol to creatine).
Results: Relative cerebral blood volume ratios were significantly different (p = 0.004) between low-grade (1.61 +/- 1.20) and high-grade tumors (5.45 +/- 1.96). The optimal relative cerebral blood volume ratio cutoff value in identification of anaplastic oligodendroglial tumors was 2.14. Analysis of MRS data showed significantly higher Cho/Cr ratios (p = 0.002) in high-grade than in low-grade tumors. A Cho/Cr ratio cutoff value of 2.33 had the highest accuracy in identification of high-grade tumors.
Conclusion: Relative cerebral blood volume measurement and MRS are helpful in differentiating low-grade from anaplastic oligodendroglial tumors.
Lee D, Choi K, Han K, Choi S, Lee N, Ahn S Neuroradiology. 2024; 66(9):1527-1535.
PMID: 39014271 DOI: 10.1007/s00234-024-03430-y.
Malik V, Kesavadas C, Thomas B, N D, K K Indian J Radiol Imaging. 2024; 34(3):382-389.
PMID: 38912247 PMC: 11188723. DOI: 10.1055/s-0043-1777742.
Patil V, Malik R, Sarawagi R Pol J Radiol. 2023; 88:e521-e528.
PMID: 38125817 PMC: 10731442. DOI: 10.5114/pjr.2023.132889.
Guida L, Stumpo V, Bellomo J, van Niftrik C, Sebok M, Berhouma M Cancers (Basel). 2022; 14(6).
PMID: 35326580 PMC: 8946242. DOI: 10.3390/cancers14061432.
Gupta M, Gupta A, Yadav V, Parvaze S, Singh A, Saini J Neuroradiology. 2021; 63(8):1227-1239.
PMID: 33469693 DOI: 10.1007/s00234-021-02636-8.